VISIT PHARMINHO
Discover regulatory status of 14000+ drugs
Access 15+ regulatory services
Structured insights, and compliance clarity—all in one place
Now Live

X

Tag: #drugcompliance

Vaayath > #drugcompliance

DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs

69th DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs Minutes of the 69th Drugs Consultative Committee (DCC) meeting held on 24.06.2026 — Agenda Nos. 2 & 3 Meeting: 69th DCC, held on 24.06.2026 Agenda 2: Comprehensive Regulatory…

Read More

DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses

69th DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses Vaayath Regulatory Desk | Drugs Consultative Committee, 69th Meeting | Held on 24.06.2026 The Drugs Consultative Committee (DCC), at its 69th meeting held on 24.06.2026, took up an…

Read More
Schedule H2 expansion

Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls

CDSCO  ·  Drugs Rules Amendment  ·  GSR 506(E) Schedule H2 Expanded: Vaccines, Antimicrobials, Narcotic Drugs & Anticancer Medicines Now Under Stricter Prescription Controls 📅 Gazette Date: 22 June 2026 ⚖️ Effective: 1 July 2027 (Antimicrobials: 1 July 2028) 🏛 Ministry…

Read More